Outlook for 2022
(Updated October 21, 2022)
The worldwide disruption in the availability of electronic components has significantly affected Bittium's ability to deliver products to its customers during this year. Some tactical communication product deliveries have already been postponed to 2023, and we have not been able to fully meet the demand for medical technology products because we have not been able to manufacture all products due to the lack of components. About 70 percent of Bittium's net sales accumulate from products and related systems, and uncertainties related to product deliveries cause significant uncertainty for the accumulation of Bittium's net sales and operating result during the end of 2022.
Bittium expects the net sales of 2022 to be at the same level as in the previous year (EUR 86.9 million in 2021), and the operating result of 2022 to be positive (EUR 3.2 million in 2021).